Navigation Links
Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
Date:11/14/2011

MENLO PARK, Calif., Nov. 14, 2011 /PRNewswire/ -- Virobay, Inc., a privately held biotechnology firm with a broad portfolio of cysteine protease inhibitors for the treatment of autoimmune diseases, neuropathic pain, liver diseases and cancer, presented data showing that one of the company's spectrum-selective cathepsin inhibitors demonstrated efficacy in a mouse model of bone cancer pain.  Virobay has a series of advanced, spectrum-selective cathepsin inhibitors with structural diversity and demonstrated activity in bone cancer and related pain.  VBY-825, a prototype compound within this series, is an orally bioavailable, highly potent, reversible inhibitor of a subset of cathepsin proteases (including cathepsins S, K, L and B) that demonstrated protection from bone destruction and remodeling in this metastatic breast cancer model, as well as significant analgesic activity.  These preclinical data suggest that Virobay's spectrum-selective cathepsin inhibitors have potential therapeutic utility in the treatment of metastatic and primary bone cancer and cancer-related bone pain, with a mechanism of action that would be highly complementary to standard chemotherapy.

The data were presented in a poster, titled "Efficacy of a Spectrum-Selective Cathepsin Inhibitor in a Mouse Model of Bone Cancer," by Holsinger, et al., at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, on Sunday, November 13th.

"These preclinical data provide a compelling demonstration of the therapeutic potential of Virobay's cathepsin inhibitors in bone cancer and bone cancer pain," said Robert Booth, PhD, Virobay's president and chief executive officer.  "The data demonstrate that the anti-tumorigenic and analgesic activity is due to the selective targeting of specific cathepsins that are known to facilitate osteolytic metastasis, bone invasion and bone matrix degradation.  We believe that these dat
'/>"/>

SOURCE Virobay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Study Shows C1-Esterase Inhibitor Concentrate is Safe and Consistently Effective for Long-Term Treatment of Hereditary Angioedema Attacks at Any Body Location
3. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
4. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
5. Enantas Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of Windhovers Top 10 Infectious Disease Projects to Watch
6. Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T
7. Modulation of inhibitory output is key function of antiobesity hormone
8. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
9. Interleukin-6 Inhibitor Sirukumab (CNTO 136) Phase 2 Data Show Promise in the Treatment of Active Rheumatoid Arthritis
10. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
11. Pharmacyclics Achieves $7 Million Development Milestone for HDAC Inhibitor, PCI-24781 / S 78454 with Servier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Today BioSpace , the leading life sciences ... campaign spotlighting the life sciences community in Illinois , ... Kansas , Michigan , Minnesota ... Ohio and Wisconsin . ... of all job postings on BioSpace originating in this region in 2013. ...
(Date:7/31/2014)... , July 31, 2014 Nearly 20,000 ... th Annual Meeting & Clinical Lab Expo in ... meeting featured never-before-seen breakthroughs in diagnostic research and technology ... they need. As of Wednesday, July 30, ... AACC Annual Meeting & Clinical Lab Expo, with more ...
(Date:7/31/2014)... good reason people over 60 are not donor candidates ... weakens with time, making the elderly prone to life-threatening ... research team now has discovered a reason why. , ... inability of blood-forming cells to maintain blood production over ... defects that could be restored for rejuvenation therapies," said ...
(Date:7/31/2014)... Turing, the British mathematician (1912-1954), is famous for a ... 20th century. In 1936 he published a paper, which ... formal concept of a computer algorithm. He next played ... the machines which cracked the German military codes, enabling ... battles. And in the late 1940,s he turned his ...
Breaking Biology Technology:Midwest Biotech Leaders Featured On BioSpace Map 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3Key to aging immune system is discovered 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 2A mathematical theory proposed by Alan Turing in 1952 can explain the formation of fingers 3
... The head of an alliance of angel investment ... together. , ,On October 19th, Susan Preston, entrepreneur in residence ... the Radisson Hotel in Appleton, Wisconsin. , ,Preston said that ... of various sizes, but only $354 million was given to ...
... coming to a close, the fourth quarter represents a fast and ... the more important of these events: , , , ... biotech activities! This is a good sign and bodes well for ... in Chicago. Its also an indicator that biotech is alive, prospering ...
... with three publicly traded biotech and health-care companies showing ... last quarter. Due to new products and investments, the ... the industry. , Bone Care: $1.2 million, boosted by ... Care International reported that for the third quarter ...
Cached Biology Technology:Susan Preston, entrepreneur, on how to set up angel networks 2Susan Preston, entrepreneur, on how to set up angel networks 3Susan Preston, entrepreneur, on how to set up angel networks 4Susan Preston, entrepreneur, on how to set up angel networks 5Furious pace of Midwest biotech events marks progress 2Furious pace of Midwest biotech events marks progress 3Wisconsin publicly traded biomedical companies report gains this quarter 2Wisconsin publicly traded biomedical companies report gains this quarter 3
(Date:7/31/2014)... of scientists from Spain, France, and the U.S. ... is the oldest definitive member of the tribe ... The discovery and description were made possible through ... imaging technique, which allows the detailed study of ... species is described in the journal Annals ...
(Date:7/31/2014)... how the brain processes speech, potentially increasing the ... at The University of Texas at Dallas. , ... Ear and Hearing , researchers demonstrated for the ... brain,s recognition of speech sounds. , Noise-induced hearing ... affecting an estimated 15 percent of Americans between ...
(Date:7/31/2014)... Rim Fire was in full fury, raging swiftly from ... the backcountry of Yosemite National Park in California,s Sierra ... the battle began to turn, enacting a case study ... to fuel large, severe fires. , "When the Rim ... fire had been used as a management tool, rather ...
Breaking Biology News(10 mins):UT Dallas study reveals effect of loud noises on brain 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5
... beetles and only two species of the tuatara, a reptile ... Crocodiles and alligators, while nearly 250 million years old, have ... including mammals and many species of birds and fish ... Scientists have often posited that because some ...
... of America (ESA) is pleased to announce the selection of ... Membership acknowledges those who have served ESA for at least ... Society that has reached an extraordinary level. Candidates for this ... voted on by the ESA membership. All four will be ...
... largely restricted to the eastern edge of the New England Tableland, and ... this flowering plant, until now classified as a variety of the Hairpin ... a distinct species. The study was published in the open access journal ... family of flowering plants that includes the Banksia and ...
Cached Biology News:Why are there so many species of beetles and so few crocodiles? 2Why are there so many species of beetles and so few crocodiles? 3Entomological Society of America names 2012 Honorary Members 2Entomological Society of America names 2012 Honorary Members 3Entomological Society of America names 2012 Honorary Members 4Botany student proves 'New England Banksia' a distinct species 2
...
Collected from calves that are 10 days old or less. Sterile, cell culture tested, US Origin...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (C7671) ... assistance. Mfr Desig: Corning ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: